Atea Pharma Says FDA Grants Fast Track Designation To AT-752 For Treatment Of Dengue

RTTNews | 955天前
Atea Pharma Says FDA Grants Fast Track Designation To AT-752 For Treatment Of Dengue

(RTTNews) - Biopharmaceutical company Atea Pharmaceuticals, Inc. (AVIR) announced Monday that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to AT-752, a novel, orally administered, direct-acting antiviral for the treatment of dengue virus infection.

AT-752, a novel, orally administered direct-acting antiviral derived from Atea's purine nucleotide prodrug platform was designed for the treatment and prophylaxis of dengue. It works by impairing the dengue viral polymerase, which then inhibits replication of the virus.

AT-752 is in Phase 2 clinical development and was generally well tolerated in a Phase 1 clinical study. In preclinical studies, AT-752 showed potent in vitro activity against all dengue serotypes, as well as potent in vivo antiviral activity in a small animal model.

For More Such Health News, visit rttnews.com

read more
Atea Pharma Rejects Unsolicited Proposal From Tang Capital Partners

Atea Pharma Rejects Unsolicited Proposal From Tang Capital Partners

Biopharmaceutical company Atea Pharmaceuticals, Inc. (AVIR) announced Tuesday that its Board of Directors unanimously rejected the unsolicited proposal from Tang Capital Partners, LP on behalf of Concentra Biosciences, LLC to acquire all outstanding common shares of Atea for $5.75 per share in cash, plus a contingent value right representing the right to receive 80% of the net proceeds payable from any license or disposition of Atea's programs.
RTTNews | 709天前
FTSE 100 Modestly Higher Ahead Of BoE Policy Announcement

FTSE 100 Modestly Higher Ahead Of BoE Policy Announcement

U.K. stocks are modestly higher on Thursday as investors await the Bank of England's monetary policy announcement later in the day. Optimism about U.S. agreeing on a trade deal with a major country is also aiding sentiment.
RTTNews | 46分钟前
CAC 40 Up More Than 1%

CAC 40 Up More Than 1%

After three successive days of losses, the French market is gaining some notable ground in positive territory on Thursday thanks to rising optimism about a trade deal. Investors, digesting recent corporate earnings updates, and the Federal Reserve's policy announcement, are also awaiting the monetary policy announcements from the Bank of England.
RTTNews | 1小时8分钟前
DAX Rises Nearly 300 Points On Results, Trade Deal Hopes

DAX Rises Nearly 300 Points On Results, Trade Deal Hopes

German stocks are up sharply on Thursday thanks to some upbeat earnings announcements and easing concerns about tariff tensions. Investors are also looking ahead to the monetary policy announcements from the Federal Reserve and the Bank of England.
RTTNews | 1小时26分钟前
Philippine Economy Expands Less Than Forecast

Philippine Economy Expands Less Than Forecast

The Philippine economy logged a weaker-than-expected growth at the start of the year on lower net exports even ahead of the implementation of trade tariffs, official data showed on Thursday. Gross domestic product grew 5.4 percent year-on-year in the first quarter, which was slightly faster than the 5.3 percent rise in the preceding period, the Philippine Statistics Authority reported.
RTTNews | 2小时7分钟前
U.S. Dollar Rises Amid U.S. Trade Deal Optimism

U.S. Dollar Rises Amid U.S. Trade Deal Optimism

The U.S. dollar strengthened against other major currencies in the European session on Thursday, after U.S. President Donald Trump said he would announce "a MAJOR TRADE DEAL WITH REPRESENTATIVES OF A BIG, AND HIGHLY RESPECTED, COUNTRY," without giving further details.
RTTNews | 2小时41分钟前
European Shares Climb Before BoE Rate Decision

European Shares Climb Before BoE Rate Decision

European stocks were moving higher on Thursday after U.S. President Donald Trump signaled progress toward a first trade deal in his global tariff dispute, without providing further details.
RTTNews | 2小时41分钟前